Merck & Co., Inc. Credit Rating

Resultados 1 - 50 de 149

Página de 3 Next

Filtrar por:

Fecha	Tipo de Reporte	Título	Fuente
11 Apr 2024	Credit Opinion	Merck & Co., Inc.: Update to credit analysis after revision in outlook to positive from stable	Moody's Investors Service
08 Apr 2024	Rating Action	Moody's Ratings affirms Merck & Co.'s A1 ratings; revises outlook to positive	Moody's Investors Service
28 Mar 2024	Peer Snapshot	Merck & Co., Inc. - December 2023 (LTM): Peer Snapshot	Moody's Investors Service
06 Dec 2023	Peer Snapshot	Merck & Co., Inc. - September 2023 (LTM): Peer Snapshot	Moody's Investors Service
27 Sep 2023	Credit Opinion	Merck & Co., Inc.: Solid growth will continue, supporting deployment of capital for acquisitions	Moody's Investors Service
15 Sep 2023	Peer Snapshot	Merck & Co., Inc. - June 2023 (LTM): Peer Snapshot	Moody's Investors Service
27 Jul 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
23 Jun 2023	Peer Snapshot	Merck & Co., Inc. - March 2023 (LTM): Peer Snapshot	Moody's Investors Service
08 May 2023	Rating Action	Moody's assigns A1 rating to Merck's sr. notes; stable outlook	Moody's Investors Service
17 Apr 2023	Announcement	Moody's: Merck's acquisition of Prometheus will strengthen immunology pipeline	Moody's Investors Service
17 Apr 2023	Issuer Comment	Merck & Co., Inc.: Merck's acquisition of Prometheus will strengthen immunology pipeline	Moody's Investors Service
07 Apr 2023	Peer Snapshot	Merck & Co., Inc. - December 2022 (LTM): Peer Snapshot	Moody's Investors Service
27 Mar 2023	Credit Opinion	Merck & Co., Inc.: Update to analysis after outlook change to stable	Moody's Investors Service
24 Mar 2023	Rating Action	Moody's affirms Merck & Co.'s A1 rating; revises outlook to stable from negative	Moody's Investors Service
09 Jan 2023	Peer Snapshot	Merck & Co., Inc. - September 2022 (LTM): Peer Snapshot	Moody's Investors Service
04 Oct 2022	Credit Opinion	Merck & Co., Inc.: Update to credit analysis – Keytruda will drive over solid operating performance, but M&A risk still present	Moody's Investors Service
04 Oct 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
12 Sep 2022	Peer Snapshot	Merck & Co., Inc. - June 2022 (LTM): Peer Snapshot	Moody's Investors Service
21 Jun 2022	Peer Snapshot	Merck & Co., Inc. - March 2022 (LTM): Peer Snapshot	Moody's Investors Service
05 Apr 2022	Peer Snapshot	Merck & Co., Inc. - December 2021 (LTM): Peer Snapshot	Moody's Investors Service
04 Apr 2022	Credit Opinion	Merck & Co., Inc.: Update to credit analysis – earnings and cash flow to temporarily benefit from molnupiravir	Moody's Investors Service
07 Dec 2021	Rating Action	Moody's assigns A1 rating to Merck's notes; negative outlook	Moody's Investors Service
30 Nov 2021	Peer Snapshot	Merck & Co., Inc. - September 2021 (LTM): Peer Snapshot	Moody's Investors Service
10 Nov 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Merck & Co., Inc.	Moody's Investors Service
04 Oct 2021	Credit Opinion	Merck & Co., Inc.: Update to credit analysis – Acceleron acquisition reduces M&A capacity	Moody's Investors Service
01 Oct 2021	Rating Action	Moody's affirms Merck's A1 ratings; revises outlook to negative	Moody's Investors Service
09 Sep 2021	Peer Snapshot	Merck & Co., Inc. - June 2021 (LTM): Peer Snapshot	Moody's Investors Service
26 Jul 2021	Credit Opinion	Merck & Co., Inc.: Update to credit analysis – Keytruda growth and cost reductions will propel strong growth	Moody's Investors Service
07 Jun 2021	Peer Snapshot	Merck & Co., Inc. - March 2021 (LTM): Peer Snapshot	Moody's Investors Service
02 Apr 2021	Peer Snapshot	Merck & Co., Inc. - December 2020 (LTM): Peer Snapshot	Moody's Investors Service
29 Jan 2021	Credit Opinion	Merck & Co., Inc.: Update to credit analysis – Keytruda growth and cost reductions will propel strong growth after Organon spinoff	Moody's Investors Service
15 Dec 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Merck & Co., Inc.	Moody's Investors Service
01 Dec 2020	Peer Snapshot	Merck & Co., Inc. - September 2020 (LTM): Peer Snapshot	Moody's Investors Service
31 Aug 2020	Peer Snapshot	Merck & Co., Inc. - June 2020 (LTM): Peer Snapshot	Moody's Investors Service
06 Aug 2020	Credit Opinion	Merck & Co., Inc.: Update to credit analysis – Keytruda growth helps mitigate ongoing coronavirus impact, with Organon spin-off pending	Moody's Investors Service
16 Jun 2020	Rating Action	Moody's assigns A1 rating to Merck's new notes; stable outlook	Moody's Investors Service
01 Jun 2020	Peer Snapshot	Merck & Co., Inc. - March 2020 (LTM): Peer Snapshot	Moody's Investors Service
03 Apr 2020	Peer Snapshot	Merck & Co., Inc. - December 2019 (LTM): Peer Snapshot	Moody's Investors Service
06 Feb 2020	Credit Opinion	Merck & Co., Inc.: Update to credit analysis after NewCo spin-off announcement	Moody's Investors Service
05 Feb 2020	Rating Action	Moody's affirms Merck's A1/Prime-1 ratings; stable outlook	Moody's Investors Service
14 Jan 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Merck & Co., Inc.	Moody's Investors Service
25 Nov 2019	Peer Snapshot	Merck & Co., Inc. - September 2019 (LTM): Peer Snapshot	Moody's Investors Service
21 Nov 2019	Credit Opinion	Merck & Co., Inc.: Update to credit analysis - Keytruda will propel solid growth, but also result in declining business diversity	Moody's Investors Service
04 Sep 2019	Peer Snapshot	Merck & Co., Inc. - June 2019 (LTM): Peer Snapshot	Moody's Investors Service
12 Jul 2019	Sector Comment	Pharmaceuticals - Global: Rising competition in HIV will steadily pressure market leader Gilead Sciences	Moody's Investors Service
29 May 2019	Peer Snapshot	Merck & Co., Inc. - March 2019 (LTM): Peer Snapshot	Moody's Investors Service
21 May 2019	Credit Opinion	Merck & Co., Inc.: Update to credit analysis - Keytruda will fuel solid growth until Januvia cliff in 2022-2023	Moody's Investors Service
02 Apr 2019	Peer Snapshot	Merck & Co., Inc. - December 2018 (LTM): Peer Snapshot	Moody's Investors Service
05 Mar 2019	Rating Action	Moody's assigns A1 rating to Merck's notes; stable outlook	Moody's Investors Service
15 Feb 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Merck & Co., Inc.	Moody's Investors Service

Resultados 1 - 50 de 149

Página de 3 Next

Estudios & Calificaciones

Productos & Soluciones

Noticias & Eventos

Usuarios Registrados

¿No se ha registrado?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: